Curebase hires Katri Langel as Senior Director of Program Development for Europe

SAN FRANCISCO, September 23, 2021 / PRNewswire / – Curebase, a Company Committed to Democratizing Access to Clinical Studies, Appoints International Computing and Clinical Trials Veteran Katri Langel as senior director of program development for the European market.

Curebase is a provider of decentralized clinical research software and services, with the goal of fueling research where any patient can participate in clinical trials at home and with their preferred physician. The platform accelerates registrations and enables new study designs with diverse populations. Curebase works as a complete eClinical software platform and virtual research site with features like digital recruiting, ePRO, eCOA, telemedicine, eConsent, eSource, etc. (PRNewsfoto / Curebase)

To upload a photo of Katri Langel, Click here.

Curebase decentralized clinical trial model ensures more diverse studies because unique populations – which are generally under-represented in clinical trials – may be included. The company’s virtual research sites also provide physicians with new and unique options for their patients, regardless of their location. The Curebase platform enables sponsors, CROs, and physicians in practices of all sizes to conduct clinical research, including private practices, independent clinics, and large academic research sites.

Langel will be responsible for business development in Europe as well as building partnership networks – including site networks, laboratories, logistics, translation, data and other support services – across the continent.

“Katri’s deep international experience in clinical trials and her understanding of different cultures and regulations in Europe make it ideal for leading our program development efforts in this region, ”said Tom lemberg, founder and CEO of Curebase. “She is comfortable working with large clients in the pharmaceutical and IT industries as well as startups. Katri’s versatility and knowledge will help us continue to grow in Europe. “

Prior to joining Curebase, Langel held the position of Senior E-Clinical Delivery Manager at Vitaccess and Director of Customer Orientation at snapIoT. She started her career in the clinical trials industry as an ePRO project manager at CRF Health (now Signant Health).

“I am very excited to join Curebase as the company combines innovative services with the technology platform. This enables a new operating model and increased flexibility, reducing operational risk and speeding up the clinical development process, ”Langel said. “From my own personal experiences, I know how difficult it is for people to participate in a clinical trial, and Curebase is working to change that.”

About Curebase
At Curebase, our mission is to bring quality medical innovations to patients faster and improve human well-being through more effective clinical studies. We prove that clinical research can be dramatically accelerated if we empower physicians around the world to recruit patients from the communities where they live. By applying cutting-edge clinical software and remote study management techniques to the problem, we are reinventing clinical trials and research from the ground up. For more information, please visit www.curebase.com.

Media contact: Grace Vinton, Account Manager, [email protected]

Cision

Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/curebase-hires-katri-langel-as-senior-director-of-program-development-for-europe-301384203.html

SOURCE Curebase

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *